VTVT
vTv Therapeutics Inc.
Key Financials
Operating Income
$-32808000
↓ 35.7%
Net Income
$-26974000
↓ 46.1%
Revenue
$0
↓ 100.0%
Total Assets
$89.9M
↑ 134.9%
Total Liabilities
$25.5M
↑ 6.2%
Shareholders' Equity
$64.4M
↑ 428.2%
Cash & Equivalents
$88.9M
↑ 142.0%
Long-term Debt
$5.0M
↓ 66.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| DEFA14A | 6/10/2026 | View on SEC |
| 424B2 | 5/13/2026 | View on SEC |
| 8-K | 5/13/2026 | View on SEC |
| S-8 | 5/13/2026 | View on SEC |
| 10-Q | 5/13/2026 | View on SEC |
| 8-K | 5/13/2026 | View on SEC |
| DEF 14A | 4/28/2026 | View on SEC |
| SCHEDULE 13G/A | 4/16/2026 | View on SEC |
| SCHEDULE 13G | 3/27/2026 | View on SEC |
| 8-K | 3/10/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | VTVT |
| Company Name | vTv Therapeutics Inc. |
| CIK | 1641489 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 336-841-0300 |